(Q35771690)

English

Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

scientific article published on June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

congenital disorder

0 references

author name string

T Abshire

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

G Kenet

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

899-909

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Platelet activity of high-dose factor VIIa is independent of tissue factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Pharmacokinetics of recombinant activated factor VII (rFVIIa).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectiveness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Clinical use of recombinant FVIIa (rFVIIa).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Deep venous thrombosis in hemophilia A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Thrombosis in a duplicated superficial femoral vein in a patient with haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Catheter-related deep venous thrombosis in children with hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Complications associated with the treatment of haemophiliacs with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Thrombogenicity of prothrombin complex concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Potential role for rFVIIa in transfusion medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00759.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2004.00759.X

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35771690&oldid=1861985437"